Literature DB >> 11925356

Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings.

Steven A Chance1, Margaret M Esiri, Timothy J Crow.   

Abstract

BACKGROUND: Claims that schizophrenia is a disease of the limbic system have been strengthened by meta-analyses of magnetic resonance imaging (MRI) studies finding reduced hippocampus and amygdala volumes. Some post-mortem studies do not find these abnormalities. AIMS: To assess the volume of the amygdala in a series of brains post-mortem.
METHOD: Amygdala volume was estimated using point-counting in both hemispheres of the brains of 10 male and 8 female patients with schizophrenia, and a comparison group of 9 males and 9 females.
RESULTS: No significant reduction of amygdala volume was found.
CONCLUSIONS: Significant volume reduction of the amygdala is not a consistent feature of schizophrenia; findings from early MRI studies using coarse delineation methods may introduce bias to subsequent meta-analyses.

Entities:  

Mesh:

Year:  2002        PMID: 11925356     DOI: 10.1192/bjp.180.4.331

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

1.  Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder.

Authors:  Yarema B Bezchlibnyk; Xiujun Sun; Jun-Feng Wang; Glenda M MacQueen; Bruce S McEwen; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

2.  Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia.

Authors:  Eric C Zimmerman; Mark Bellaire; Samuel G Ewing; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

3.  Lack of gender influence on cortical and subcortical gray matter development in childhood-onset schizophrenia.

Authors:  Brian Weisinger; Deanna Greenstein; Anand Mattai; Liv Clasen; Francois Lalonde; Sara Feldman; Rachel Miller; Julia W Tossell; Nora S Vyas; Reva Stidd; Christopher David; Nitin Gogtay
Journal:  Schizophr Bull       Date:  2011-05-25       Impact factor: 9.306

Review 4.  Stereological approaches to identifying neuropathology in psychosis.

Authors:  Karl-Anton Dorph-Petersen; David A Lewis
Journal:  Biol Psychiatry       Date:  2010-08-01       Impact factor: 13.382

5.  Bilaterally reduced claustral volumes in schizophrenia and major depressive disorder: a morphometric postmortem study.

Authors:  Hans-Gert Bernstein; Anna Ortmann; Henrik Dobrowolny; Johann Steiner; Ralf Brisch; Tomasz Gos; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-31       Impact factor: 5.270

6.  The effects of changing water content, relaxation times, and tissue contrast on tissue segmentation and measures of cortical anatomy in MR images.

Authors:  Ravi Bansal; Xuejun Hao; Feng Liu; Dongrong Xu; Jun Liu; Bradley S Peterson
Journal:  Magn Reson Imaging       Date:  2013-09-20       Impact factor: 2.546

7.  In vivo estimation of normal amygdala volume from structural MRI scans with anatomical-based segmentation.

Authors:  Achilleas Siozopoulos; Vasilios Thomaidis; Panos Prassopoulos; Aliki Fiska
Journal:  Surg Radiol Anat       Date:  2017-08-31       Impact factor: 1.246

Review 8.  Abnormal structure or function of the amygdala is a common component of neurodevelopmental disorders.

Authors:  Cynthia M Schumann; Melissa D Bauman; David G Amaral
Journal:  Neuropsychologia       Date:  2010-10-13       Impact factor: 3.139

9.  Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia.

Authors:  Julien Matricon; Alfredo Bellon; Helge Frieling; Oussama Kebir; Gwenaëlle Le Pen; Frédéric Beuvon; Catherine Daumas-Duport; Thérèse M Jay; Marie-Odile Krebs
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

10.  Hippocampal volume and shape analysis in an older adult population.

Authors:  Tara L McHugh; Andrew J Saykin; Heather A Wishart; Laura A Flashman; Howard B Cleavinger; Laura A Rabin; Alexander C Mamourian; Li Shen
Journal:  Clin Neuropsychol       Date:  2007-01       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.